Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Grant or award Director acquired 54,825 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 114,218 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Executive Chair bought 43,994 shares at $0.57 ($24,918)
  7. 4 Open-market buy President and CEO bought 98,000 shares at $0.76 ($74,892)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 73,656 shares (grant or award)
  10. 4 Grant or award Director acquired 99,671 shares (grant or award)
  11. 4 Grant or award Director acquired 72,937 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award President and CEO acquired 23,033 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 330 shares (grant or award)
  18. 4 Grant or award Director acquired 423 shares (grant or award)
  19. 4 Grant or award Director acquired 15,902 shares (grant or award)
  20. 4 Grant or award Director acquired 14,728 shares (grant or award)

Page 9 of 28 · 551 filings